Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02056535 · ClinicalTrials.gov registry record · Phase 2

Screening and Brief Intervention in the ED Among Mexican-origin Young Adults

A Phase 2 study, sponsored by Public Health Institute, California.

Completed
Registry status
Phase 2
Development phase
698
Enrollment target

NCT02056535: Completed Phase 2 study, sponsored by Public Health Institute, California.

NCT02056535 is a Phase 2 study that has completed, run by Public Health Institute, California. The registered enrollment target is 698 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (425% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02056535, a Phase 2 study, has completed, sponsored by Public Health Institute, California.

COMPLETED
Registry status
Phase 2
Development phase
698 participants
Enrollment target

Study Summary

The aims of this study are to: 1) examine the effectiveness of Screening, Brief Intervention and Referral to Treatment (SBIRT) among Mexican-origin young adults (age 18-25), using a motivational intervention delivered by a Health Promotion Advocate, relative to standard care with and without assessment, on a reduction in heavy drinking and alcohol-related problems in the emergency department (ED) at the U.S.-Mexico border; and, 2) identify variables that are related to effectiveness of the intervention and that predict successful treatment outcome. Patients will be re-assessed by telephone at three and twelve months to evaluate outcomes.The specific hypotheses to be examined in this proposal are: 1) the motivational interview will lead to significantly greater reductions in the maximum number of drinks on an occasion and in Rapid Alcohol Problem Screen (RAPS4) score at the 12-month follow-up compared to standard care without assessment (those who screen positive but are not assessed) as well as compared to standard care with assessment; 2) the motivational interview will lead to significantly greater reductions in number of drinking days per week, average number of drinks per day, maximum number of drinks on an occasion, RAPS4 score, and number of negative consequences of drinking at 3-month and 12-month follow-up compared to standard care with assessment; 3) a positive breath alcohol concentration (BAC) at the time of the ED visit and/or self-reported drinking prior to the event resulting in the ED visit will be positively predictive of effectiveness of the intervention; 4) attributing a causal association of drinking and the reason for the ED visit will be positively associated with effectiveness of brief intervention; 5) readiness to change (and stage of change) will be positively associated with effectiveness of brief intervention; 6) risk taking/impulsivity and sensation seeking dispositions will be negatively associated with effectiveness of brief intervention

Primary Outcome

Change to less than 15 or more drinks per week for males (8 or more per week for females), and 5 or more drinks on occasion for males (4 or more for females)

Interventions

  • BEHAVIORAL Brief Motivational Intervention

Trial Details

FieldValue
Enrollment Target 698 participants
Start Date 2010-05
Est. Completion 2013-10
Phase Phase 2

What the finished NCT02056535 record still lists

NCT02056535 is an interventional study that assigns participants to a tested intervention. The registered 698 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (425% higher).

The record links to 0 conditions, and to 1 intervention - of which Brief Motivational Intervention is the first listed.

NCT02056535 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02056535 about?

NCT02056535 is a clinical study titled "Screening and Brief Intervention in the ED Among Mexican-origin Young Adults". The aims of this study are to: 1) examine the effectiveness of Screening, Brief Intervention and Referral to Treatment (SBIRT) among Mexican-origin young adults (age 18-25), using a motivational intervention delivered by a Health Promotion Advocate, relative to standard care with and without assessm...

What is the current status of trial NCT02056535?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 698 participants. The study started on 2010-05. Estimated completion is 2013-10.

What interventions are being tested in trial NCT02056535?

The interventions under investigation include: Brief Motivational Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02056535?

This trial is sponsored by Public Health Institute, California, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02056535's enrollment target sits among peer trials

698 46th of 2000 higher than 1,955 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03136094 · 698 participants · NA

    Suicide in Urban Natives: Detection and Networks to Combat Events

  • NCT04928846 · 698 participants · Phase 3

    A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  • NCT05943535 · 698 participants · Phase 3

    Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • NCT07187115 · 699 participants · NA

    A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02056535, the US trial registry maintained by the National Library of Medicine. NCT02056535 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.